BACKGROUND: Lactoferrin is a mammalian milk glycoprotein involved in innate immunity. Recent data show that bovine lactoferrin (bLF) prevents late-onset sepsis in preterm very low birth weight (VLBW) neonates. METHODS: This is a secondary analysis of data from a multicenter randomized controlled trial where preterm VLBW neonates randomly received bLF (100 mg/day; group A1), bLF + Lactobacillus rhamnosus GG (106colony-forming units per day; group A2), or placebo (group B) for 6 weeks. Here we analyze the incidence rates of fungal colonization, invasive fungal infection (IFI), and rate of progression from colonization to infection in all groups. RESULTS: This study included 472 neonates whose clinical, nutritional, and demographical characteristics were similar. Overall, the incidence of fungal colonization was comparable (17.6%, 16.6%, and 18.5% in A1, A2, and B, respectively; P = .89 [A1] and .77 [A2]). In contrast, IFIs were significantly decreased in A1 and A2 (0.7% and 2.0%, respectively) compared with B (7.7%; P = .002 [A1] and .02 [A2]), and this was significantly true both in <1000 g (0.9% [A1] and 5.6% [A2], vs 15.0%) and in 1001 to 1500 g infants (0% and 0% vs 3.7%). The progression rate colonization-infection was significantly lower in the bLF groups: 3.7% (A1) and 12% (A2), vs 41.9%; P < .001 (A1) and P = .02 (A2). No IFI-attributable deaths occurred in the treatment groups, versus 2 in placebo. No adverse effects or intolerances occurred. CONCLUSIONS: Prophylactic oral administration of bLF reduces the incidence of IFI in preterm VLBW neonates. No effect is seen on colonization. The protective effect on IFI is likely due to limitation of ability of fungal colonies to progress toward invasion and systemic disease in colonized infants. Copyright © 2012 by the American Academy of Pediatrics.

Bovine lactoferrin prevents invasive fungal infections in very low birth weight infants: A randomized controlled trial / Manzoni, Paolo; Stolfi, Ilaria; Messner, Hubert; Cattani, Silvia; Laforgia, Nicola; Romeo, Mario G.; Bollani, Lina; Rinaldi, Matteo; Gallo, Elena; Quercia, Michele; Maule, Milena; Mostert, Michael; Decembrino, Lidia; Magaldi, Rosario; Mosca, Fabio; Vagnarelli, Federica; Memo, Luigi; Betta, Pasqua M.; Stronati, Mauro; Farina, Daniele. - In: PEDIATRICS. - ISSN 0031-4005. - 129:1(2012), pp. 116-123. [10.1542/peds.2011-0279]

Bovine lactoferrin prevents invasive fungal infections in very low birth weight infants: A randomized controlled trial

Cattani, Silvia;Mosca, Fabio;
2012

Abstract

BACKGROUND: Lactoferrin is a mammalian milk glycoprotein involved in innate immunity. Recent data show that bovine lactoferrin (bLF) prevents late-onset sepsis in preterm very low birth weight (VLBW) neonates. METHODS: This is a secondary analysis of data from a multicenter randomized controlled trial where preterm VLBW neonates randomly received bLF (100 mg/day; group A1), bLF + Lactobacillus rhamnosus GG (106colony-forming units per day; group A2), or placebo (group B) for 6 weeks. Here we analyze the incidence rates of fungal colonization, invasive fungal infection (IFI), and rate of progression from colonization to infection in all groups. RESULTS: This study included 472 neonates whose clinical, nutritional, and demographical characteristics were similar. Overall, the incidence of fungal colonization was comparable (17.6%, 16.6%, and 18.5% in A1, A2, and B, respectively; P = .89 [A1] and .77 [A2]). In contrast, IFIs were significantly decreased in A1 and A2 (0.7% and 2.0%, respectively) compared with B (7.7%; P = .002 [A1] and .02 [A2]), and this was significantly true both in <1000 g (0.9% [A1] and 5.6% [A2], vs 15.0%) and in 1001 to 1500 g infants (0% and 0% vs 3.7%). The progression rate colonization-infection was significantly lower in the bLF groups: 3.7% (A1) and 12% (A2), vs 41.9%; P < .001 (A1) and P = .02 (A2). No IFI-attributable deaths occurred in the treatment groups, versus 2 in placebo. No adverse effects or intolerances occurred. CONCLUSIONS: Prophylactic oral administration of bLF reduces the incidence of IFI in preterm VLBW neonates. No effect is seen on colonization. The protective effect on IFI is likely due to limitation of ability of fungal colonies to progress toward invasion and systemic disease in colonized infants. Copyright © 2012 by the American Academy of Pediatrics.
129
1
116
123
Bovine lactoferrin prevents invasive fungal infections in very low birth weight infants: A randomized controlled trial / Manzoni, Paolo; Stolfi, Ilaria; Messner, Hubert; Cattani, Silvia; Laforgia, Nicola; Romeo, Mario G.; Bollani, Lina; Rinaldi, Matteo; Gallo, Elena; Quercia, Michele; Maule, Milena; Mostert, Michael; Decembrino, Lidia; Magaldi, Rosario; Mosca, Fabio; Vagnarelli, Federica; Memo, Luigi; Betta, Pasqua M.; Stronati, Mauro; Farina, Daniele. - In: PEDIATRICS. - ISSN 0031-4005. - 129:1(2012), pp. 116-123. [10.1542/peds.2011-0279]
Manzoni, Paolo; Stolfi, Ilaria; Messner, Hubert; Cattani, Silvia; Laforgia, Nicola; Romeo, Mario G.; Bollani, Lina; Rinaldi, Matteo; Gallo, Elena; Quercia, Michele; Maule, Milena; Mostert, Michael; Decembrino, Lidia; Magaldi, Rosario; Mosca, Fabio; Vagnarelli, Federica; Memo, Luigi; Betta, Pasqua M.; Stronati, Mauro; Farina, Daniele
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate

Caricamento pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/11380/1160783
Citazioni
  • ???jsp.display-item.citation.pmc??? 49
  • Scopus 118
  • ???jsp.display-item.citation.isi??? 110
social impact